Background: Rhinoviruses (RVs) are ubiquitous respiratory pathogens that often cause mild or subclinical infections. Molecular detection of RVs from the upper respiratory tract can be prolonged, complicating etiologic association in persons with severe lower respiratory tract infections. Little is known about RV viremia and its value as a diagnostic indicator in persons hospitalized with community-acquired pneumonia (CAP). Methods: Sera from RV-positive children and adults hospitalized with CAP were tested for RV by real-time reverse-transcription polymerase chain reaction. Rhinovirus species and type were determined by partial genome sequencing. Results: Overall, 57 of 570 (10%) RV-positive patients were viremic, and all were children aged <10 years (n = 57/375; 15.2%). Although RV-A was the most common RV species detected from respiratory specimens (48.8%), almost all viremias were RV-C (98.2%). Viremic patients had fewer codetected pathogens and were more likely to have chest retractions, wheezing, and a history of underlying asthma/reactive airway disease than patients without viremia. Conclusions: More than 1 out of 7 RV-infected children aged <10 years hospitalized with CAP were viremic. In contrast with other RV species, RV-C infections were highly associated with viremia and were usually the only respiratory pathogen identified, suggesting that RV-C viremia may be an important diagnostic indicator in pediatric pneumonia. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Background: Rhinoviruses (RVs) are ubiquitous respiratory pathogens that often cause mild or subclinical infections. Molecular detection of RVs from the upper respiratory tract can be prolonged, complicating etiologic association in persons with severe lower respiratory tract infections. Little is known about RV viremia and its value as a diagnostic indicator in persons hospitalized with community-acquired pneumonia (CAP). Methods: Sera from RV-positive children and adults hospitalized with CAP were tested for RV by real-time reverse-transcription polymerase chain reaction. Rhinovirus species and type were determined by partial genome sequencing. Results: Overall, 57 of 570 (10%) RV-positive patients were viremic, and all were children aged <10 years (n = 57/375; 15.2%). Although RV-A was the most common RV species detected from respiratory specimens (48.8%), almost all viremias were RV-C (98.2%). Viremic patients had fewer codetected pathogens and were more likely to have chest retractions, wheezing, and a history of underlying asthma/reactive airway disease than patients without viremia. Conclusions: More than 1 out of 7 RV-infected children aged <10 years hospitalized with CAP were viremic. In contrast with other RV species, RV-C infections were highly associated with viremia and were usually the only respiratory pathogen identified, suggesting that RV-C viremia may be an important diagnostic indicator in pediatric pneumonia. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Jari Suvilehto; Merja Roivainen; Mikko Seppänen; Seppo Meri; Tapani Hovi; Olli Carpén; Anne Pitkäranta Journal: J Clin Virol Date: 2005-11-08 Impact factor: 3.168
Authors: Seema Jain; Derek J Williams; Sandra R Arnold; Krow Ampofo; Anna M Bramley; Carrie Reed; Chris Stockmann; Evan J Anderson; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; Anami Patel; Weston Hymas; James D Chappell; Robert A Kaufman; J Herman Kan; David Dansie; Noel Lenny; David R Hillyard; Lia M Haynes; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Richard G Wunderink; Kathryn M Edwards; Andrew T Pavia; Jonathan A McCullers; Lyn Finelli Journal: N Engl J Med Date: 2015-02-26 Impact factor: 91.245
Authors: E Kathryn Miller; Kathryn M Edwards; Geoffrey A Weinberg; Marika K Iwane; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Laura-Lee Morin; Luke H Heil; Xiaoyan Lu; John V Williams Journal: J Allergy Clin Immunol Date: 2008-11-22 Impact factor: 10.793
Authors: Riku Erkkola; Riitta Turunen; Kati Räisänen; Matti Waris; Tytti Vuorinen; Miia Laine; Paula Tähtinen; James E Gern; Yury A Bochkov; Aino Ruohola; Tuomas Jartti Journal: Pediatr Infect Dis J Date: 2020-04 Impact factor: 3.806
Authors: Timothy Choi; Mark Devries; Leonard B Bacharier; William Busse; Carlos A Camargo; Robyn Cohen; Gregory P Demuri; Michael D Evans; Anne M Fitzpatrick; Peter J Gergen; Kristine Grindle; Rebecca Gruchalla; Tina Hartert; Kohei Hasegawa; Gurjit K Khurana Hershey; Patrick Holt; Kiara Homil; Tuomas Jartti; Meyer Kattan; Carolyn Kercsmar; Haejin Kim; Ingrid A Laing; Petra LeBeau; Kristine E Lee; Peter N Le Souëf; Andrew Liu; David T Mauger; Carole Ober; Tressa Pappas; Shilpa J Patel; Wanda Phipatanakul; Jacqueline Pongracic; Christine Seroogy; Peter D Sly; Christopher Tisler; Ellen R Wald; Robert Wood; Ronald Gangnon; Daniel J Jackson; Robert F Lemanske; James E Gern; Yury A Bochkov Journal: Am J Respir Crit Care Med Date: 2021-04-01 Impact factor: 30.528
Authors: Natasha S Ching; Despina Kotsanas; Mee L Easton; Michelle J Francis; Tony M Korman; Jim P Buttery Journal: J Paediatr Child Health Date: 2018-06-06 Impact factor: 1.954
Authors: Jane Kuypers; Garrett A Perchetti; Helen Y Chu; Kira L Newman; Joanne Katz; Subarna K Khatry; Steven C LeClerq; Keith R Jerome; James M Tielsch; Janet A Englund Journal: J Med Virol Date: 2019-08-21 Impact factor: 2.327
Authors: Kirsten Alexandra Eberhardt; Charlotte Meyer-Schwickerath; Eva Heger; Elena Knops; Clara Lehmann; Jan Rybniker; Philipp Schommers; Dennis A Eichenauer; Florian Kurth; Michael Ramharter; Rolf Kaiser; Udo Holtick; Florian Klein; Norma Jung; Veronica Di Cristanziano Journal: Viruses Date: 2020-09-18 Impact factor: 5.048